Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Identification of biomarkers for glycaemic deterioration in type 2 diabetes.
Nat. Commun. 14:2533 (2023)
We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing 2,973 individuals across three molecular classes, metabolites, lipids and proteins. Homocitrulline, isoleucine and 2-aminoadipic acid, eight triacylglycerol species, and lowered sphingomyelin 42:2;2 levels are predictive of faster progression towards insulin requirement. Of ~1,300 proteins examined in two cohorts, levels of GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 are associated with faster progression, whilst SMAC/DIABLO, SPOCK1 and HEMK2 predict lower progression rates. In an external replication, proteins and lipids are associated with diabetes incidence and prevalence. NogoR/RTN4R injection improved glucose tolerance in high fat-fed male mice but impaired it in male db/db mice. High NogoR levels led to islet cell apoptosis, and IL-18R antagonised inflammatory IL-18 signalling towards nuclear factor kappa-B in vitro. This comprehensive, multi-disciplinary approach thus identifies biomarkers with potential prognostic utility, provides evidence for possible disease mechanisms, and identifies potential therapeutic avenues to slow diabetes progression.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Altmetric
16.600
0.000
1
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
2-aminoadipic Acid; Obese Women; Weight-loss; Protein; Receptor; Expression; Homocitrulline; Association; Deficiency; Metabolism
Language
english
Publication Year
2023
HGF-reported in Year
2023
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
Journal
Nature Communications
Quellenangaben
Volume: 14,
Issue: 1,
Article Number: 2533
Publisher
Nature Publishing Group
Publishing Place
London
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502600-001
Grants
Faculty of Medicine at Lund University
Swedish Research Council
Swedish Foundation for Strategic Research
Wellcome Trust New Investigator Award
Wellcome Trust Investigator Award
MRC
Experimental Challenge Grant (DIVA)
Diabetes UK Project
Canada Research Chair in Adipocyte Development
Swedish governmental funding of clinical research (ALF)
Vinnova Swelife
Innovative Medicines Initiative 2 Joint Undertaking
Innovation Canada
European Union
EFPIA
Swiss State Secretariat for Education, Research and Innovation (SERI)
Icelandic Research Fund
Netherlands Organisation for Health Research and Development
CIHR
Wellcome Trust
CIHR Project Grant
Swedish Research Council
Swedish Foundation for Strategic Research
Wellcome Trust New Investigator Award
Wellcome Trust Investigator Award
MRC
Experimental Challenge Grant (DIVA)
Diabetes UK Project
Canada Research Chair in Adipocyte Development
Swedish governmental funding of clinical research (ALF)
Vinnova Swelife
Innovative Medicines Initiative 2 Joint Undertaking
Innovation Canada
European Union
EFPIA
Swiss State Secretariat for Education, Research and Innovation (SERI)
Icelandic Research Fund
Netherlands Organisation for Health Research and Development
CIHR
Wellcome Trust
CIHR Project Grant
WOS ID
001025265700001
Scopus ID
85158018722
PubMed ID
37137910
Erfassungsdatum
2023-11-27